INFLUX-50 (FLUNIXIN MEGLUMINE INJECTION) STERILE INJECTABLE SOLUTION DIN 02239149
Status: Cancelled Post Market
Holder: VETOQUINOL N A INC
Molecule: FLUNIXIN (FLUNIXIN MEGLUMINE)
Available to quote
Health Canada record
| Active ingredient(s) | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular; Intravenous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 02-Mar-1999 |
| Current status date | 06-Jun-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Vetoquinol N A Inc. — licence 100448, currently licensed, last inspection rating C (2025-10-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLUNIXIN (FLUNIXIN MEGLUMINE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02457180 | BANAMINE | INTERVET CANADA CORP | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 00465305 | BANAMINE | INTERVET CANADA CORP | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 02240510 | FLUNAZINE | BIMEDA-MTC ANIMAL HEALTH INC | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 02563584 | FLUTREXIN | MODERN VETERINARY THERAPEUTICS LLC | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 02550474 | SOLNIXON | BIMEDA-MTC ANIMAL HEALTH INC | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 02234061 | SOLVEZINE | NORBROOK LABORATORIES LTD. | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Marketed |
| 00465291 | BANAMINE GRANULES | SCHERING-PLOUGH CANADA INC | Granules | FLUNIXIN (FLUNIXIN MEGLUMINE) 25 MG | Cancelled Post Market |
| 02231381 | CITATION INJECTION | BAYER INC., ANIMAL HEALTH | Liquid | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Cancelled Post Market |
| 02230652 | CRONYXIN INJECTION | CROSS VETPHARM GROUP LTD | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Cancelled Post Market |
| 02248807 | SUPPRESSOR | NORBROOK LABORATORIES LTD. | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Cancelled Post Market |
| 02478951 | VETONIXIN | NORBROOK LABORATORIES LTD. | Solution | FLUNIXIN (FLUNIXIN MEGLUMINE) 50 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 3620 | 2003-01-17 | New Drug Submission (NDS) | |
| 6763 | 1998-11-27 | New Drug Submission (NDS) |